Asset Details
Do you wish to reserve the book?
The prevalence and outcomes of inflammatory bowel disease among patients with cytomegalovirus disease
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
The prevalence and outcomes of inflammatory bowel disease among patients with cytomegalovirus disease
Do you wish to request the book?
The prevalence and outcomes of inflammatory bowel disease among patients with cytomegalovirus disease
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
The prevalence and outcomes of inflammatory bowel disease among patients with cytomegalovirus disease
2025
Overview
Aims: Cytomegalovirus (CMV) colitis in individuals with inflammatory bowel disease (IBD) is a serious condition. The present study evaluated the prevalence and outcome of IBD-CMV colitis among patients with CMV disease. Methods: We performed a retrospective study to evaluate the patients with IBD and CMV colitis between January 1, 2017, and December 31, 2022. We identified IBD-CMV colitis based on the presence of CMV in tissue or a polymerase chain reaction (PCR) result of >1000 copies/mL with no other clinical explanations. The frequency of IBD-CMV colitis, relapse rate, requirement of surgical interventions, and associated mortality were assessed. Results: Out of 163 patients with CMV disease screened, 28 (17.2%) were diagnosed with CMV colitis and IBD [median age: 54 (19-67) years, male: 77%]. The frequency of ulcerative colitis and Crohn's disease was 93% and 7%, respectively. Most CMV PCR assays (97%) were performed using serum, whereas the remaining tests were performed using serum and tissue samples. CMV was not detected via immunohistochemistry or hematoxylin-eosin staining in any patient. Antiviral treatment was initiated in 74% of the patients and lasted a median of 20 days (6-32 days). No surgical interventions or disease-related deaths were identified. Conclusions: This electronic medical records study showed that IBD-CMV colitis was a rare disease among patients with CMV disease and generally followed a favorable course. Keywords: Inflammatory bowel disease, cytomegalovirus, diagnosis, treatment, prognosis
Publisher
Galenos Yayinevi Tic. Ltd
